Sleep Disorders in Chronic Kidney Disease Patients

Background: Chronic kidney disease (CKD) is associated with a variety of comorbidities, including sleep disorders, which significantly impact patients' quality of life. Sleep disturbances in CKD patients are underreported and poorly managed, despite their potential to exacerbate CKD-related complications. Aim of the study: This study aims to assess the prevalence and types of sleep disorders among CKD patients and explore their clinical characteristics. Methods: A cross-sectional study was conducted on 50 CKD patients at conducted at the Department of Nephrology, Medical College for Women& Hospital, Dhaka Bangladesh. During 1 year from January 2024 to December 2024. Sleep disorders were evaluated using the Pittsburgh Sleep Quality Index (PSQI) and Epworth Sleepiness Scale (ESS). Clinical and demographic data were also collected. Result: The study revealed that 40% of participants experienced insomnia, 30% had obstructive sleep apnea (OSA), 20% suffered from restless legs syndrome (RLS), and 10% reported excessive daytime sleepiness. A total of 80% of the participants exhibited poor sleep quality based on the PSQI score, and 30% showed excessive daytime sleepiness according to the ESS. The majority of patients were in advanced stages of CKD (stage 5D), with a high prevalence of comorbidities such as hypertension and diabetes mellitus. Conclusion: In our study, sleep disorders were highly prevalent in CKD patients, significantly affecting their quality of life. The findings underscore the need for routine screening and management of sleep disturbances in this population. Further research is needed to explore the mechanisms linking CKD and sleep disorders, as well as the efficacy of targeted interventions to improve sleep quality in these patients.